𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An open clinical trial of clonazepam in the treatment of patients with recurrent panic attacks

✍ Scribed by Beaudry, Paul; Fontaine, Rejean; Chouinard, Guy; Annable, Lawrence

Book ID
122065541
Publisher
Elsevier Science
Year
1985
Tongue
English
Weight
324 KB
Volume
9
Category
Article
ISSN
0278-5846

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A short-term open trial of clomipramine
A short-term open trial of clomipramine in the treatment of patients with panic attacks
✍ F. K. Judd; G. D. Burrows; P. F. Marriott; P. Farnbach; S. Blair-West; T. R. Nor πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 668 KB

Clomipramine was used to treat 14 patients with panic attacks. Diagnosis was made according to DSM-111 criteria for agoraphobia with panic attacks or panic disorder uncomplicated. An open evaluation of the drug over an 8-week treatment period was conducted. A total of 10 patients completed the study

The efficacy of reboxetine in the treatm
The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study
✍ P. N. Dannon; I. Iancu; L. Grunhaus πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 57 KB πŸ‘ 2 views

## Abstract ## Background and Objective Selective serotonin reuptake inhibitors (SSRIs) are currently the first‐line treatment for panic disorder, although up to 30% of patients either do not respond to SSRIs or withdraw due to adverse events. Reboxetine, a selective norepinephrine reuptake inhibi